Sherbrooke Park Advisers »

Amneal Pharmaceuticals shares owned by Sherbrooke Park Advisers

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Sherbrooke Park Advisers from 13F filings

Historical chart of Sherbrooke Park Advisers investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Sherbrooke Park Advisers

Quarter filed Position value Share count Share price at filing
2024-09-30 $554k 67k 8.32
2023-09-30 $54k 13k 4.22

More positions owned by Sherbrooke Park Advisers

Gap (GAP)
Smartsheet Com Cl A (SMAR)
Lennar Corp Cl A (LEN)
Pure Storage Cl A (PSTG)
Micron Technology (MU)
Campbell Soup Company (CPB)
Ida (IDA)
AeroVironment (AVAV)
Pagerduty (PD)
Devon Energy Corporation (DVN)
Korn Ferry Com New (KFY)
Cardinal Health (CAH)
ConAgra Foods (CAG)
Amazon (AMZN)
Cirrus Logic (CRUS)

View all positions for Sherbrooke Park Advisers

Top funds holding Amneal Pharmaceuticals

Vanguard Group
BlackRock
Tpg Gp A
Rubric Capital Management
Citadel Advisors
Dimensional Fund Advisors
Geode Capital Management
Neuberger Berman Group
State Street Corporation
Nantahala Capital Management
Nuveen Asset Management
BlackBarn Capital Partners
Invesco
Northern Trust
Acadian Asset Management

View all funds holding Amneal Pharmaceuticals